Please assess the completion status of the following clinical trial:

Trial Title: Evaluate Effectiveness of Epiduo® Gel in Reducing Antibiotic Sensitive & Resistant Strains of Propionibacterium (P)Acnes

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy adult male or female subjects 18 years of age and older, with no past or present history of any significant internal disease~* Subjects who:~  * show a high degree of fluorescence of the facial skin under a Wood's lamp, indicating the presence of P acnes~ * have Baseline P acnes count of \> 10,000 per cm2 CFU of the facial skin (forehead)~ * have high level resistance to erythromycin, variable resistance to clindamycin, resistance to tetracycline and variable resistance to doxycycline and minocycline~Exclusion Criteria:~* Subjects who exhibit any skin disorders of an acute or chronic nature (e.g., psoriasis, eczema, etc)~* Subjects who have taken topical or systemic antibiotics within 4 weeks prior to baseline assessments~* Subjects who have used other medications which may influence skin surface P acnes levels~* Subjects who are unwilling to refrain from using toners, astringents or other drying agents on the face during the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Study Treatment (Type: EXPERIMENTAL): Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel (Epiduo® Gel)~Other Names:~Epiduo® Gel Apply once daily

Based on this trial design, predict the completion outcome and termination type (if applicable).